Literature DB >> 18570380

Mapping the UDP-glucuronic acid binding site in UDP-glucuronosyltransferase-1A10 by homology-based modeling: confirmation with biochemical evidence.

Rajat Banerjee1, Matthew W Pennington, Amanda Garza, Ida S Owens.   

Abstract

The UDP-glucuronosyltransferase (UGT) isozyme system is critical for protecting the body against endogenous and exogenous chemicals by linking glucuronic acid donated by UDP-glucuronic acid to a lipophilic acceptor substrate. UGTs convert metabolites, dietary constituents, and environmental toxicants to highly excretable glucuronides. Because of difficulties associated with purifying endoplasmic reticulum-bound UGTs for structural studies, we carried out homology-based computer modeling to aid analysis. The search found structural homology in Escherichia coli UDP-galactose 4-epimerase. Consistent with predicted similarities involving the common UDP moiety in substrate/inhibitor, UDP-glucose and UDP-hexanol amine caused competitive inhibition by Lineweaver-Burk plots. Among predicted binding sites N292, K314, K315, and K404 in UGT1A10, two informative sets of mutants K314R/Q/A/E/G and K404R/E had null activities or 2.7-fold higher/50% less activity, respectively. Scatchard analysis of binding data of the affinity ligand, 5-azidouridine-[beta- (32)P]diphosphoglucuronic acid, to purified UGT1A10-His or UGT1A7-His revealed high- and low-affinity binding sites. 2-Nitro-5-thiocyanobenzoic acid-digested UGT1A10-His bound with the radiolabeled affinity ligand revealed an 11.3 and 14.3 kDa peptide associated with K314 and K404, respectively, in a discontinuous SDS-PAGE system. Similar treatment of 1A10His-K314A bound with the ligand lacked both peptides; 1A10-HisK404R- and 1A10-HisK404E showed 1.3-fold greater and 50% less label in the 14.3 kDa peptide, respectively, compared to 1A10-His without affecting the 11.3 kDa peptide. Scatchard analysis of binding data of the affinity ligand to 1A10His-K404R and -K404E showed a 6-fold reduction and a large increase in K d, respectively. Our results indicate that K314 and K404 are required UDP-glcA binding sites in 1A10, that K404 controls activity and high-affinity sites, and that K314 and K404 are strictly conserved in 70 aligned UGTs, except for S321, equivalent to K314, in UGT2B15 and 2B17 and I321 in the inactive UGT8, which suggests UGT2B15 and 2B17 contain suboptimal activity. Hence our data strongly support UDP-glcA binding to K314 and K404 in UGT1A10.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570380      PMCID: PMC2587317          DOI: 10.1021/bi8006127

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Lobular distribution of human liver phenol and bilirubin uridine 5'-diphosphate glucuronosyltransferase messenger RNAs.

Authors:  F Chen; J Zhou; J K Ritter; C A Bondy; I S Owens
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

2.  Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.

Authors:  F Wright; R Poizat; M Bongini; F Bozzolan; A Doukani; P Mauvais-Jarvis
Journal:  J Clin Endocrinol Metab       Date:  1985-02       Impact factor: 5.958

3.  Structural analysis of UDP-sugar binding to UDP-galactose 4-epimerase from Escherichia coli.

Authors:  J B Thoden; A D Hegeman; G Wesenberg; M C Chapeau; P A Frey; H M Holden
Journal:  Biochemistry       Date:  1997-05-27       Impact factor: 3.162

4.  Determination of catalytic key amino acids and UDP sugar donor specificity of the cyanohydrin glycosyltransferase UGT85B1 from Sorghum bicolor. Molecular modeling substantiated by site-specific mutagenesis and biochemical analyses.

Authors:  Karina Sinding Thorsøe; Søren Bak; Carl Erik Olsen; Anne Imberty; Christelle Breton; Birger Lindberg Møller
Journal:  Plant Physiol       Date:  2005-09-16       Impact factor: 8.340

5.  Evidence for overlapping active sites for 17 alpha-ethynlestradiol and bilirubin in the human major bilirubin UDPglucuronosyltransferase.

Authors:  M Ciotti; I S Owens
Journal:  Biochemistry       Date:  1996-08-06       Impact factor: 3.162

6.  Purification and immunochemical characterization of a low-pI form of UDP glucuronosyltransferase from mouse liver.

Authors:  P I Mackenzie; L M Hjelmeland; I S Owens
Journal:  Arch Biochem Biophys       Date:  1984-06       Impact factor: 4.013

7.  Purification and properties of 4-hydroxybiphenyl UDP-glucuronyltransferase from bovine liver microsomes.

Authors:  H Kanehara; H Yokota; M Sato; A Yuasa
Journal:  J Biochem       Date:  1992-11       Impact factor: 3.387

8.  Purification and properties of a form of UDP-glucuronyltransferase from liver microsomes of 3-methylcholanthrene-treated rats.

Authors:  H Yokota; A Yuasa; R Sato
Journal:  J Biochem       Date:  1988-10       Impact factor: 3.387

9.  Modulation of the number of ligand binding sites of UDP-glucuronyltransferase by the gel to liquid-crystal phase transition of phosphatidylcholines.

Authors:  Y Hochman; M Kelley; D Zakim
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

10.  Molecular structure of the NADH/UDP-glucose abortive complex of UDP-galactose 4-epimerase from Escherichia coli: implications for the catalytic mechanism.

Authors:  J B Thoden; P A Frey; H M Holden
Journal:  Biochemistry       Date:  1996-04-23       Impact factor: 3.162

View more
  4 in total

Review 1.  Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.

Authors:  Ryoichi Fujiwara; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Front Pharmacol       Date:  2016-10-24       Impact factor: 5.810

2.  Computing highly correlated positions using mutual information and graph theory for G protein-coupled receptors.

Authors:  Sarosh N Fatakia; Stefano Costanzi; Carson C Chow
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

Review 3.  Revisiting the Latency of Uridine Diphosphate-Glucuronosyltransferases (UGTs)-How Does the Endoplasmic Reticulum Membrane Influence Their Function?

Authors:  Yuejian Liu; Michael W H Coughtrie
Journal:  Pharmaceutics       Date:  2017-08-30       Impact factor: 6.321

4.  Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTs.

Authors:  Mario Öeren; Peter J Walton; Peter A Hunt; David J Ponting; Matthew D Segall
Journal:  J Comput Aided Mol Des       Date:  2020-06-12       Impact factor: 3.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.